Clinical Trial Update: Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab in elderly patients with relapsed diffuse large…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Disease
• Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vorinostat (vorinostat)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hodgkin's Disease, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-11-07